DrugPatentWatch Database Preview
Osmotica Company Profile
What is the competitive landscape for OSMOTICA, and when can generic versions of OSMOTICA drugs launch?
OSMOTICA has nine approved drugs.
There are four US patents protecting OSMOTICA drugs.
There are eleven patent family members on OSMOTICA drugs in nine countries and two supplementary protection certificates in two countries.
Summary for Osmotica
| International Patents: | 11 |
| US Patents: | 4 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 9 |
| Patent Litigation for Osmotica: | See patent lawsuits for Osmotica |
Drugs and US Patents for Osmotica
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osmotica Pharm | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-002 | Feb 16, 2018 | RX | Yes | No | 10,213,393 | Start Trial | Start Trial | ||||
| Osmotica Pharm | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-001 | Feb 16, 2018 | RX | Yes | No | 10,213,394 | Start Trial | Start Trial | ||||
| Osmotica | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-002 | Jul 28, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Osmotica | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-005 | Jul 28, 2017 | RX | No | Yes | Start Trial | Start Trial | |||||
| Osmotica | OMTRYG | omega-3-acid ethyl esters type a | CAPSULE;ORAL | 204977-001 | Apr 23, 2014 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Osmotica | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205629-003 | Jul 7, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Osmotica
International Patents for Osmotica Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5325421 | Start Trial |
| European Patent Office | 1834638 | Start Trial |
| Spain | 2549581 | Start Trial |
| Argentina | 053986 | Start Trial |
| Brazil | PI0515761 | Start Trial |
| European Patent Office | 2965753 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Osmotica Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0296560 | SPC/GB97/023 | United Kingdom | Start Trial | PRODUCT NAME: DONEPEZIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE HYDROCHLORIDE; REGISTERED: UK PL 10555/0006 19970214; UK PL 10555/0007 19970214 |
| 0296560 | 2/1998 | Austria | Start Trial | PRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
